UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer Journal article
Sun, Yidan, Yang, Xinyu, Ren, Shiqi, Lu, Zhichao, Liu, Zongheng, Kong, Fanming, Wang, Ziheng, Yang, Yang. Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer[J]. Journal of Men's Health, 2023, 19(11), 16-33.
Authors:  Sun, Yidan;  Yang, Xinyu;  Ren, Shiqi;  Lu, Zhichao;  Liu, Zongheng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:0.6/0.6 | Submit date:2024/01/10
Immune Checkpoint Inhibitor  Immunotherapy  Prognostic Model  Prostate Cancer  Tumor Immune Microenvironment  
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery Journal article
Wang, Ting, Tang, Yuting, Pan, Wenjun, Yan, Botao, Hao, Yifan, Zeng, Yunli, Chen, Zexin, Lan, Jianqiang, Zhao, Shuhan, Deng, Chuxia, Zheng, Hang, Yan, Jun. Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery[J]. Diseases of the Colon and Rectum, 2023, 66(5), 733-743.
Authors:  Wang, Ting;  Tang, Yuting;  Pan, Wenjun;  Yan, Botao;  Hao, Yifan; et al.
Favorite | TC[WOS]:11 TC[Scopus]:10  IF:3.2/4.0 | Submit date:2023/06/05
Drug Tests  Patient-derived Tumor Organoid  Predictive Model  Prognostic Value  Progression-free Survival  Stage Iv Colorectal Cancer